Senate Committee Holds Hearing on CRISPR Science, Ethical Concerns, Regulatory ApproachesGenomeWebNEW YORK (GenomeWeb) – The US Senate Committee on Health, Education, Labor, and Pensions this week held a hearing on CRISPR genome editing, with senators … Continue reading
|
Seattle Children’s launches $1 billion campaign with plans to build new immunotherapy research center
GeekWire As part of that initiative, the organization unveiled plans to build a new 540,000 square foot immunotherapy research center in downtown Seattle, called Building Cure. The center will focus on researching immunotherapy treatments for a huge variety of … |
The Sun |
Epicutaneous Immunotherapy for Peanut Allergy Investigated
Monthly Prescribing Reference (HealthDay News) — A 250-μg peanut patch produces a significant treatment response in peanut-allergic patients treated for a year, according to a study published online Nov. 14 in the Journal of the American Medical Association. Hugh A. Sampson, M.D., … Peanut patch allowing traces to seep into the skin DOES work and ‘could CURE deadly allergy’The Sun |
NEWS.com.au |
Genes altered inside a person for the first time ever
NEWS.com.au Safety issues plagued some earlier gene therapies. One worry is that the virus might provoke an immune system attack. In 1999, 18-year-old Jesse Gelsinger died in a gene therapy study from that problem, but the new studies use a different virus that’s … Doctors are attempting the first case of gene editing inside the body of a living humanQuartz Experimental new technique aims to edit man’s DNA inside his own bodyThe Verge The First Man to Have His Genes Edited Inside His BodyThe Atlantic Newsweek –Discover Magazine (blog) –ABC News all 35 news articles » |
FierceBiotech |
Harnessing immunotherapy to reverse Type 1 diabetes
FierceBiotech Scientists at Boston Children’s Hospital have come up with a way to thwart this wayward autoimmune reaction, and it involves a protein that plays a prominent role in new immunotherapy treatments for cancer: PD-L1. PD-L1 is called an immune “checkpoint” … |